跳至主要内容
临床试验/NCT03190057
NCT03190057终止不适用

Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Seung-Jung Park8 个研究点 分布在 1 个国家目标入组 218 人开始时间: 2019年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
218
试验地点
8
主要终点
Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)

研究概览

简要总结

The objective of this study is to evaluate effectiveness and safety of BIOFREEDOM™ FAMILY stent in the "real world" daily practice as compared with other drug-eluting stents.

详细描述

BIOFREEDOM™ FAMILY stent means that Biofreedom stent, Biofreedom Ultra and the other stents with names starting with Biofreedom.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 19 and more
  • Patient with BIOFREEDOM™ FAMILY stent
  • Written consent

排除标准

  • Intervention with BIOFREEDOM™ FAMILY stent and other drug eluting stent at the same time
  • Life-expectancy less than 1 year
  • Cardiac shock

结局指标

主要结局

Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)

时间窗: 1 year

次要结局

  • Stroke(5 year)
  • All cause death(5 year)
  • Cardiac death(5 year)
  • Myocardial Infarction(5 year)
  • Composite event rate of death or myocardial infarction (MI)(5 year)
  • Composite event rate of cardiac death or myocardial infarction (MI)(5 year)
  • Target- Vessel Revascularization(5 year)
  • Target- Lesion Revascularization(5 year)
  • Stent thrombosis(5 year)
  • Procedural Success rate(5 day)

研究者

发起方
Seung-Jung Park
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Seung-Jung Park

Professor, Division of Cardiology, Department of Medicine, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine

Asan Medical Center

研究点 (8)

Loading locations...

相似试验